Sign In
Buy DNLI
$19.66
+0.310 (+1.60%)
At Close: Jun 03, 2026
Head-To-Head Comparison: Orchard Therapeutics (NASDAQ:ORTX) and Denali Therapeutics (NASDAQ:DNLI)
07:08am, Wednesday, 26'th Feb 2020
Orchard Therapeutics (NASDAQ:ORTX) and Denali Therapeutics (NASDAQ:DNLI) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of the
Could Denali Therapeutics Inc.’s (NASDAQ:DNLI) Investor Composition Influence The Stock Price?
11:48am, Tuesday, 25'th Feb 2020
Every investor in Denali Therapeutics Inc. (NASDAQ:DNLI) should be aware of the most powerful shareholder groups...
Jefferies starts Denali Therapeutics at Buy ahead of 'lots of catalysts in 2020' DNLI;SNY;BIIB
12:04pm, Monday, 24'th Feb 2020
Jefferies starts Denali Therapeutics at Buy ahead of 'lots of catalysts in 2020' Jefferies DNLI SNY BIIB
Brokerages Anticipate Denali Therapeutics Inc (NASDAQ:DNLI) Will Announce Earnings of -$0.49 Per Share
02:48am, Friday, 21'st Feb 2020
Equities research analysts expect Denali Therapeutics Inc (NASDAQ:DNLI) to announce earnings of ($0.49) per share for the current quarter, according to Zacks. Four analysts have issued estimates for D
Stifel likes Alector and Denali in premarket analyst action
12:06pm, Wednesday, 19'th Feb 2020
Alector (NASDAQ:ALEC) initiated with Buy rating and $44 (52% upside) price target at Stifel.Aridis Pharmaceuticals (NASDAQ:ARDS) initiated with Buy rating and $18 (193% upside) price target at Roth Ca
Three Expensive Biotech Stocks To Avoid
05:50pm, Monday, 17'th Feb 2020
Tesla's stock is often criticized as overpriced. These three biotechs are way more expensive.
3 Stocks That Are Way More Expensive Than Tesla
03:06pm, Monday, 17'th Feb 2020
3 Stocks That Are Way More Expensive Than Tesla, Stocks: TSLA,ADVM,FIXX,FTSV,IMMU,DNLI,TELL, release date:Feb 17, 2020
Denali Therapeutics chief medical officer sets a cultural standard
08:00pm, Friday, 14'th Feb 2020
Chief Medical Officer and Head of Development Company: Denali Therapeutics HQ: South San Francisco Years at company: 5 Career turning point: Switching from clinical medicine to research and moving
Denali Therapeutics Inc. (DNLI) Upgraded to Strong Buy: What Does It Mean for the Stock?
05:00pm, Friday, 14'th Feb 2020
Denali Therapeutics Inc. (DNLI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Denali Therapeutics Inc. (DNLI) Upgraded to Strong Buy: What Does It Mean for the Stock?
05:00pm, Friday, 14'th Feb 2020
Denali Therapeutics Inc. (DNLI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Has Denali Therapeutics (DNLI) Outpaced Other Medical Stocks This Year?
04:30pm, Friday, 07'th Feb 2020
Is (DNLI) Outperforming Other Medical Stocks This Year?
Has Denali Therapeutics (DNLI) Outpaced Other Medical Stocks This Year?
04:30pm, Friday, 07'th Feb 2020
Is (DNLI) Outperforming Other Medical Stocks This Year?
Denali Therapeutics Inc (NASDAQ:DNLI) Given Consensus Rating of "Buy" by Analysts
08:46am, Thursday, 06'th Feb 2020
Denali Therapeutics Inc (NASDAQ:DNLI) has received an average recommendation of “Buy” from the nine ratings firms that are covering the stock, MarketBeat reports. Two research analysts have rated
Wedbush Weighs in on Denali Therapeutics Inc's Q1 2020 Earnings (NASDAQ:DNLI)
07:00am, Tuesday, 04'th Feb 2020
Denali Therapeutics Inc (NASDAQ:DNLI) – Wedbush upped their Q1 2020 earnings estimates for Denali Therapeutics in a report released on Wednesday, January 29th. Wedbush analyst L. Chico now anticipat
Aimmune's Palforzia Wins FDA Approval for Peanut Allergy
04:11pm, Monday, 03'rd Feb 2020
Aimmune's (AIMT) Palforzia is the first medicine to receive an FDA nod for treating patients with peanut allergy. Shares rise in pre-market trading.
